Protalix Biotherapeutics Inc (NYSE American:PLX)

Delayed Data
As of 4:00pm ET
 -0.04 / -1.13%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +213.39% increase from the last price of 3.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.46%
Growthannually 84.55%


Growthquarterly 23.63%
Growthannually 12.03%
Key to the earnings and sales forecast charts.